Comparing Atripla vs Biktarvy
| Atripla | Biktarvy |
|
|---|
| Atripla (efavirenz / emtricitabine / tenofovir) | Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for HIV Infection, Nonoccupational Exposure, Occupational Exposure. Atripla may also be used for purposes not listed in this medication guide. |
Prescription only
Biktarvy is a combination tablet that contains three antiviral agents which may be used to treat HIV-1 in adults and children weighing more than 25kg (55lb). It is generally well-tolerated and the... View more |
Related suggestions Popular comparisons
|
|||||||||||||||
| More about Atripla (efavirenz / emtricitabine / tenofovir) | More about Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) | ||||||||||||||||
| Generic Status | |||||||||||||||||
|
No lower-cost generic available |
|||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Atripla has an average rating of 9.1 out of 10 from a total of 106 ratings on Drugs.com. 91% of reviewers reported a positive effect, while 3% reported a negative effect. |
Biktarvy has an average rating of 6.9 out of 10 from a total of 171 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 23% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
Common side effects include:
See also: Atripla side effects in more detail. |
See also: Biktarvy side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Atripla prices and generic prices |
View all Biktarvy prices |
||||||||||||||||
| Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
55 hours |
180 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 797 drugs are known to interact with Atripla:
|
A total of 387 drugs are known to interact with Biktarvy:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
July 12, 2006 |
February 07, 2018 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
|
N/A |
|||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.